---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-044892"
form_type: "8-K"
ticker: "ABT"
cik: "0000001800"
company_name: "ABBOTT LABORATORIES"
filed_at: "2026-04-17T23:59:59+00:00"
generated_at: "2026-05-15T05:33:49.234462+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Abbott reaches settlement in shareholder derivative suit over infant formula; governance reforms, up to $15.85M fees

## Summary
- Settlement of consolidated derivative action alleging fiduciary breaches and securities violations related to infant formula recall.
- Abbott to adopt corporate governance reforms; no admission of wrongdoing.
- Lead plaintiffs' counsel seeks up to $15.85M in fees/expenses and service awards up to $15,000 each.
- Court approval hearing set for June 4, 2026; shareholder objections due by May 18, 2026.
- Dismissal with prejudice of all claims; governance enhancements to improve compliance oversight.

## SEC filing metadata
- accession: 0001104659-26-044892
- form_type: 8-K
- ticker: ABT
- cik: 0000001800
- company_name: ABBOTT LABORATORIES
- filed_at: 2026-04-17T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1800/000110465926044892/0001104659-26-044892-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1800/000110465926044892/tm2611915d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-044892
- JSON: https://secwatch.observer/filing/0001104659-26-044892.json
- Plain text: https://secwatch.observer/filing/0001104659-26-044892.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.